Latest Articles
March 30, 2017
Ambry Talks Plans for Personalized Genomic Test Launch, Third Annual Trivia Night a Hit
Ambry Genetics’ Clinical Genomics Marketing Manager Layla Shahmirzadi, MS, CGC, discusses plans to launch a personalized genomic test for healthy individuals to an audience of…
Genetic Counselors
Genetic Testing
Whole Exome Sequencing
March 30, 2017
Dr. Rachid Karam Discusses Variant Classification at 2017 ACMG Annual Meeting
During the 2017 ACMG Annual Meeting, Rachid Karam, MD, PhD, discussed how understanding VUS results can help clinicians create medical management plans for their patients.
Genetic Testing
Splicing
Variant of Unknown Significance
VUS
March 21, 2017
Recapping Ambry at the 2017 Annual Meeting on Women’s Cancer
Ambry Genetics experts and collaborators presented new research at this year’s Annual Meeting on Women’s Cancer.
March 14, 2017
Four Reasons Why Genetic Testing Matters to the Individual with Colorectal Cancer
Colorectal cancer is third most common cancer diagnosed in both American men and women. Here are four points for patients on how genetic testing can…
Awareness
Clinical Research
Colorectal Cancer
Family History
Genetic Testing
March 2, 2017
RNA Labs—How they Impact the Medical World
By having the ATG Lab at Ambry, it is possible to further refine VUS results and look beyond DNA in order to determine the benign…
BRCA1 & 2
Genetic Testing
Variant of Unknown Significance
VUS
February 16, 2017
Scientific Research Consent Made Easy
Now anyone can participate in a scientific research study through AmbryShare’s simplified consent process.
AmbryShare
Clinical Research
HBOC
New England Journal of Medicine
![overlay-bottom[1]](https://ambrygen.com/wp-content/uploads/2026/02/overlay-bottom1.svg)